Wall Street Access Asset Management, LLC Gilead Sciences, Inc. Transaction History
Wall Street Access Asset Management, LLC
- $261 Million
- Q3 2024
A detailed history of Wall Street Access Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wall Street Access Asset Management, LLC holds 8,244 shares of GILD stock, worth $765,043. This represents 0.27% of its overall portfolio holdings.
Number of Shares
8,244
Previous 8,106
1.7%
Holding current value
$765,043
Previous $556,000
24.28%
% of portfolio
0.27%
Previous 0.23%
Shares
33 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
993MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.1 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.74 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.58 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...